Event Description
3rd World Conference on Pediatrics, Neonatology, and Infectious Diseases London United Kingdom

With great pleasure and anticipation, we extend our heartfelt invitation to the 3rd World Conference on Pediatrics, Neonatology, and Infectious Diseases, which will be held in the dynamic city of London, UK, on July 1415, 2025. Leading authorities, researchers, and medical professionals from around the world will come together for this esteemed event, which promises to be an extraordinary gathering of brilliant minds and dedicated professionals to exchange the most recent developments and cutting-edge techniques in the domains of pediatrics, infectious diseases, and child health.

The Pediatric Conference 2025, which has as its main focus “Innovations in Child Health and Paediatric Drug Development“, will provide a premier forum for the exchange of state-of-the-art findings, the investigation of new trends, and the debate of innovative therapeutic approaches for paediatric care. A stellar lineup of keynote speakers, panel discussions, and interactive sessions will be included at the event.

Pediatric Conference 2025 will cover important subjects like vaccine development, neonatal care, pediatric infectious diseases, and the difficulties presented by uncommon children ailments and many more.

The conference will feature a wide range of networking opportunities in addition to scientific lectures, giving attendees a special opportunity to connect with international leaders in the fields of pediatrics, drug development, and associated healthcare businesses. In addition, attendees will gain access to interactive workshops, cutting-edge product demonstrations, and expert-led sessions that promote networking and professional growth.

This conference promises to be an essential experience for anyone in the medical field, whether you are an experienced practitioner, a researcher at the forefront of medical innovation, a student eager to learn from experts, or a pharmaceutical professional involved in paediatric drug development. Public health policymakers and clinical trial specialists will also find valuable insights into the evolving landscape of child healthcare and treatment development.

Join us in London for two days of enlightening discussion, knowledge-sharing, and the advancement of child healthcare.

End Date
Start Date
Event Types (Select all that apply)
Medical Conference
Event Registration Contact Email
metthewraynott@gmail.com
Event Information Contact Email
metthewraynott@gmail.com
CME Credits
Yes
Abstract Submission Deadline
Abstract guidelines

Abstract: No more than 250 words briefly specifying the aims of the work, the main results obtained, and the conclusions drawn.

Keywords: 3–6 keywords (in alphabetical order) which will enable a subsequent information retrieval system to locate the paper.

Introduction: Describing the background of the work and its aims.

Materials and Methods: A brief description of the methods/techniques used (the principles of these methods should not be described if readers can be directed to easily accessible references or standard texts).

Results and Discussion: A clear presentation of experimental results obtained, highlighting any trends or points of interest.

Conclusions: A brief explanation of the significance and implications of the work reported.

Acknowledgements: Collate acknowledgements in a separate section at the end of the article before the references and do not, therefore, include them on the title page, as a footnote to the title or otherwise. List here those individuals who provided help during the research (e.g., providing language help, writing assistance or proof reading the article, etc.).

References: These should be to accessible sources. Please ensure that all work cited in the text is included in the reference list, and that the dates and authors given in the text match those in the reference list. References must always be given in sufficient detail for the reader to locate the work cited (see below for formats).

Biography: Brief curriculum vitae should also be provided for the presenting author at the end of the paper.

(Example: Dr. Edward studied Chemistry at the Sofia University, Bulgaria and graduated as MS in 1999. She then joined the research group of Prof. James at the Institute of General and Inorganic Chemistry, Bulgarian Academy of Sciences (IGIC-BAS). She received her PhD degree in 2004 at the same institution. After one year postdoctoral fellowship supervised by Dr Williams at the Catalysis and Spectrochemistry Laboratory, France she obtained the position of an Associate Professor at the IGIC. She has published more than 70 research articles in SCI(E) journals.)

ACKNOWLEDGMENT

The heading of the Acknowledgment section, the References section and the Biography section must not be numbered.

REFERENCES

  1. S. M. Metev and V. P. Veiko, Laser Assisted Microtechnology, 2nd ed., R. M. Osgood, Jr., Ed.  Berlin, Germany: Springer-Verlag, 1998.
  2. J. Breckling, Ed., The Analysis of Directional Time Series: Applications to Wind Speed and Direction, ser. Lecture Notes in Statistics.  Berlin, Germany: Springer, 1989, vol. 61.
  3. S. Zhang, C. Zhu, J. K. O. Sin, and P. K. T. Mok, “A novel ultrathin elevated channel low-temperature poly-Si TFT,” IEEE Electron Device Lett., vol. 20, pp. 569–571, Nov. 1999.
  4. M. Wegmuller, J. P. von der Weid, P. Oberson, and N. Gisin, “High resolution fiber distributed measurements with coherent OFDR,” in Proc. ECOC’00, 2000, paper 11.3.4, p. 109.
  5. R. E. Sorace, V. S. Reinhardt, and S. A. Vaughn, “High-speed digital-to-RF converter,” U.S. Patent 5 668 842, Sep. 16, 1997.
  6. (2007) The IEEE website. [Online]. Available
  7. M. Shell. (2007) IEEEtran webpage on CTAN. [Online]. Available:
  8. FLEXChip Signal Processor (MC68175/D), Motorola, 1996.
  9. “PDCA12-70 data sheet,” Opto Speed SA, Mezzovico, Switzerland.
  10. Karnik, “Performance of TCP congestion control with rate feedback: TCP/ABR and rate adaptive TCP/IP,” M. Eng. thesis, Indian Institute of Science, Bangalore, India, Jan. 1999.
  11. J. Padhye, V. Firoiu, and D. Towsley, “A stochastic model of TCP Reno congestion avoidance and control,” Univ. of Massachusetts, Amherst, MA, CMPSCI Tech. Rep. 99-02, 1999.
  12. Wireless LAN Medium Access Control (MAC) and Physical Layer (PHY) Specification, IEEE Std. 802.11, 1997.
  13.  
  14.  

Details of presenting author to be mentioned in certificate:

Name:

Affiliation:

Country:

Other Details:

Presentation Category: (Oral/Poster Presentation) 

Session Name: 

Email:

Alternative email:

Contact Number:

Twitter/Facebook/LinkedIn:  
Suggestion of speakers to be invited: Names and email address of your colleagues or friends interested to attend.

(+1) 206-575-7771
Medical Events Worldwide
12922 SE 299th Street, Auburn WA 98092 USA